Allotex
PrivateLast Round
Series B
Extension
Nov 30, 2023
Total Funding Raised
$46.7M
Company Overview
Allotex operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series B Extension round in November 2023.
Allotex is a biotechnology and medical device company that develops tissue-based solutions for refractive vision correction using precisely-shaped human corneal allografts.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allotex Comparables
Compare Allotex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TECLens, Inc. | 80% | |
| CorneaGen | 78% | |
| LinkoCare Life Sciences | 74% |
For institutional investors. Book with your work email.
Allotex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Nov 30, 2023 | ||||
| Series B | Jul 9, 2023 | ||||
| Series B | Feb 1, 2018 |
For institutional investors. Book with your work email.
Allotex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KCK MedTech | Series B Extension, Series B |
| Junson Capital | Series B, Series B Extension |
| Supernova Invest | Series B Extension, Series B |
| Panakès Partners | Series B |
| Exor | Series B |
| Exor Ventures | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 32% MoM.
- Jul 9, 2023
$30M round led by KCK MedTech.
For institutional investors. Book with your work email.
Allotex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Allotex's valuation, stock price, and market status.
Is Allotex a public or private company?
Allotex is a private company.
What is the current stock price of Allotex?
Allotex is a private company, so its shares have no public market price. Caplight tracks Allotex's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Allotex worth (valuation)?
Valuation information for Allotex is not publicly available.
Can I buy Allotex stock?
Allotex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Allotex's last funding round?
Allotex's most recent funding round was Series B Extension on November 30, 2023.
Who are the main investors in Allotex?
Key investors in Allotex include KCK MedTech.
Will Allotex IPO soon?
No public IPO plans have been announced for Allotex.
How can I track Allotex secondary market activity?
Caplight tracks bids, offers, and trades in Allotex's shares on secondary markets.